ANIP logo

ANI Pharmaceuticals (ANIP) Net Income

Annual Net Income

$18.78 M
+$66.67 M+139.21%

December 31, 2023


Summary


Performance

ANIP Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIPprofitabilitymetrics:

Quarterly Net Income

-$24.17 M
-$21.88 M-956.67%

September 30, 2024


Summary


Performance

ANIP Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIPprofitabilitymetrics:

TTM Net Income

-$7.09 M
-$34.11 M-126.25%

September 30, 2024


Summary


Performance

ANIP TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIPprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ANIP Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+139.2%-343.1%-153.0%
3 y3 years+183.3%-1779.4%+73.1%
5 y5 years+21.2%-244.7%-419.1%

ANIP Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+139.2%-232.7%at low-120.0%+89.5%
5 y5-yearat high+139.2%-232.7%at low-120.0%+89.5%
alltimeall time-34.7%+136.4%-215.1%+25.6%-119.9%+89.5%

ANI Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$24.17 M(+956.7%)
-$7.09 M(-126.2%)
Jun 2024
-
-$2.29 M(-112.6%)
$27.02 M(-24.0%)
Mar 2024
-
$18.21 M(+1476.4%)
$35.55 M(+89.3%)
Dec 2023
$18.78 M(-139.2%)
$1.16 M(-88.4%)
$18.78 M(+40.3%)
Sep 2023
-
$9.94 M(+59.2%)
$13.38 M(-359.4%)
Jun 2023
-
$6.25 M(+334.0%)
-$5.16 M(-80.4%)
Mar 2023
-
$1.44 M(-133.9%)
-$26.33 M(-45.0%)
Dec 2022
-$47.90 M(+12.4%)
-$4.24 M(-50.7%)
-$47.90 M(-29.3%)
Sep 2022
-
-$8.60 M(-42.4%)
-$67.79 M(+6.5%)
Jun 2022
-
-$14.92 M(-25.9%)
-$63.64 M(+1.3%)
Mar 2022
-
-$20.13 M(-16.6%)
-$62.82 M(+47.5%)
Dec 2021
-$42.60 M(+88.9%)
-$24.14 M(+442.7%)
-$42.60 M(+92.8%)
Sep 2021
-
-$4.45 M(-68.5%)
-$22.10 M(+28.3%)
Jun 2021
-
-$14.11 M(<-9900.0%)
-$17.22 M(+11.5%)
Mar 2021
-
$86.00 K(-102.4%)
-$15.45 M(-31.5%)
Dec 2020
-$22.55 M(-470.0%)
-$3.63 M(-937.6%)
-$22.55 M(-5.1%)
Sep 2020
-
$434.00 K(-103.5%)
-$23.75 M(+17.1%)
Jun 2020
-
-$12.34 M(+76.0%)
-$20.29 M(+1385.1%)
Mar 2020
-
-$7.01 M(+45.0%)
-$1.37 M(-122.4%)
Dec 2019
$6.09 M(-60.7%)
-$4.83 M(-224.1%)
$6.09 M(-62.7%)
Sep 2019
-
$3.90 M(-40.9%)
$16.36 M(-6.5%)
Jun 2019
-
$6.58 M(+1366.6%)
$17.50 M(+27.8%)
Mar 2019
-
$449.00 K(-91.7%)
$13.69 M(-11.6%)
Dec 2018
$15.49 M(-1540.0%)
$5.43 M(+7.8%)
$15.49 M(+3461.8%)
Sep 2018
-
$5.04 M(+81.4%)
$435.00 K(+268.6%)
Jun 2018
-
$2.78 M(+23.4%)
$118.00 K(+436.4%)
Mar 2018
-
$2.25 M(-123.4%)
$22.00 K(-102.0%)
Dec 2017
-$1.08 M(-127.4%)
-$9.63 M(-304.0%)
-$1.08 M(-114.4%)
Sep 2017
-
$4.72 M(+76.1%)
$7.47 M(+41.1%)
Jun 2017
-
$2.68 M(+132.7%)
$5.30 M(+41.6%)
Mar 2017
-
$1.15 M(-206.7%)
$3.74 M(-4.9%)
Dec 2016
$3.93 M(-74.4%)
-$1.08 M(-142.5%)
$3.93 M(-50.1%)
Sep 2016
-
$2.54 M(+126.0%)
$7.89 M(-20.4%)
Jun 2016
-
$1.13 M(-16.4%)
$9.91 M(-19.8%)
Mar 2016
-
$1.35 M(-53.2%)
$12.35 M(-19.7%)
Dec 2015
$15.38 M(-46.5%)
$2.88 M(-36.9%)
$15.38 M(-54.1%)
Sep 2015
-
$4.56 M(+27.7%)
$33.50 M(-6.1%)
Jun 2015
-
$3.57 M(-18.3%)
$35.69 M(+19.9%)
Mar 2015
-
$4.37 M(-79.2%)
$29.76 M(+3.5%)
Dec 2014
$28.75 M(+9482.3%)
$21.00 M(+211.4%)
$28.75 M(+157.3%)
Sep 2014
-
$6.75 M(-385.5%)
$11.17 M(+98.9%)
Jun 2014
-
-$2.36 M(-170.3%)
$5.62 M(+65.3%)
Mar 2014
-
$3.36 M(-2.1%)
$3.40 M(-251.0%)
Dec 2013
$300.00 K(-101.1%)
$3.43 M(+188.2%)
-$2.25 M(-76.7%)
Sep 2013
-
$1.19 M(-126.0%)
-$9.67 M(-43.1%)
Jun 2013
-
-$4.58 M(+100.1%)
-$16.98 M(-14.0%)
Mar 2013
-
-$2.29 M(-42.6%)
-$19.74 M(-28.8%)
Dec 2012
-$27.72 M(-46.3%)
-$3.99 M(-34.9%)
-$27.72 M(-8.8%)
Sep 2012
-
-$6.12 M(-16.6%)
-$30.38 M(-17.9%)
Jun 2012
-
-$7.34 M(-28.5%)
-$36.99 M(-17.1%)
Mar 2012
-
-$10.26 M(+54.4%)
-$44.62 M(-13.5%)
DateAnnualQuarterlyTTM
Dec 2011
-$51.61 M(+11.7%)
-$6.65 M(-47.8%)
-$51.61 M(-11.4%)
Sep 2011
-
-$12.73 M(-15.0%)
-$58.23 M(+2.0%)
Jun 2011
-
-$14.98 M(-13.2%)
-$57.09 M(+7.9%)
Mar 2011
-
-$17.25 M(+30.0%)
-$52.91 M(+14.5%)
Dec 2010
-$46.20 M(-2.8%)
-$13.27 M(+14.5%)
-$46.20 M(-29.4%)
Sep 2010
-
-$11.59 M(+7.4%)
-$65.41 M(+8.7%)
Jun 2010
-
-$10.79 M(+2.4%)
-$60.19 M(+11.4%)
Mar 2010
-
-$10.54 M(-67.6%)
-$54.02 M(+13.7%)
Dec 2009
-$47.53 M(+172.8%)
-$32.49 M(+409.9%)
-$47.53 M(+193.2%)
Sep 2009
-
-$6.37 M(+37.9%)
-$16.21 M(-1.3%)
Jun 2009
-
-$4.62 M(+14.1%)
-$16.42 M(-8.0%)
Mar 2009
-
-$4.05 M(+247.6%)
-$17.85 M(+2.4%)
Dec 2008
-$17.43 M(+129.8%)
-$1.17 M(-82.3%)
-$17.43 M(-2.8%)
Sep 2008
-
-$6.59 M(+8.9%)
-$17.93 M(+37.5%)
Jun 2008
-
-$6.05 M(+66.8%)
-$13.04 M(+38.8%)
Mar 2008
-
-$3.63 M(+116.6%)
-$9.39 M(+23.9%)
Dec 2007
-$7.58 M(-371.7%)
-$1.67 M(-1.1%)
-$7.58 M(-346.3%)
Sep 2007
-
-$1.69 M(-29.5%)
$3.08 M(-23.5%)
Jun 2007
-
-$2.40 M(+32.1%)
$4.03 M(-4.2%)
Mar 2007
-
-$1.82 M(-120.2%)
$4.20 M(+50.6%)
Dec 2006
$2.79 M(-128.9%)
$8.99 M(-1306.5%)
$2.79 M(-132.3%)
Sep 2006
-
-$745.10 K(-66.5%)
-$8.64 M(-11.4%)
Jun 2006
-
-$2.22 M(-31.1%)
-$9.75 M(-3.5%)
Mar 2006
-
-$3.23 M(+32.0%)
-$10.11 M(+4.7%)
Dec 2005
-$9.65 M(-19.7%)
-$2.45 M(+32.0%)
-$9.65 M(-14.8%)
Sep 2005
-
-$1.85 M(-28.2%)
-$11.33 M(-8.2%)
Jun 2005
-
-$2.58 M(-6.8%)
-$12.35 M(+0.1%)
Mar 2005
-
-$2.77 M(-32.9%)
-$12.34 M(+2.7%)
Dec 2004
-$12.02 M(+101.6%)
-$4.13 M(+43.8%)
-$12.02 M(+25.8%)
Sep 2004
-
-$2.87 M(+11.5%)
-$9.55 M(+17.6%)
Jun 2004
-
-$2.57 M(+5.3%)
-$8.12 M(+13.4%)
Mar 2004
-
-$2.45 M(+47.3%)
-$7.16 M(+20.1%)
Dec 2003
-$5.96 M(+56.4%)
-$1.66 M(+15.3%)
-$5.96 M(+26.5%)
Sep 2003
-
-$1.44 M(-11.0%)
-$4.71 M(+15.7%)
Jun 2003
-
-$1.62 M(+29.8%)
-$4.07 M(+3.1%)
Mar 2003
-
-$1.24 M(+202.6%)
-$3.95 M(+3.7%)
Dec 2002
-$3.81 M(+45.9%)
-$411.40 K(-48.6%)
-$3.81 M(-20.8%)
Sep 2002
-
-$801.00 K(-46.4%)
-$4.81 M(+31.4%)
Jun 2002
-
-$1.50 M(+35.6%)
-$3.66 M(+21.0%)
Mar 2002
-
-$1.10 M(-21.9%)
-$3.02 M(+15.8%)
Dec 2001
-$2.61 M(-24.0%)
-$1.41 M(-504.3%)
-$2.61 M(+22.8%)
Sep 2001
-
$349.20 K(-140.7%)
-$2.13 M(-31.3%)
Jun 2001
-
-$858.90 K(+24.5%)
-$3.10 M(-15.7%)
Mar 2001
-
-$689.90 K(-25.5%)
-$3.67 M(+6.8%)
Dec 2000
-$3.44 M(+144.4%)
-$926.50 K(+49.3%)
-$3.44 M(+36.9%)
Sep 2000
-
-$620.70 K(-56.7%)
-$2.51 M(+32.8%)
Jun 2000
-
-$1.43 M(+214.7%)
-$1.89 M(+157.1%)
Mar 2000
-
-$455.80 K(+63.1%)
-$735.20 K(+163.1%)
Dec 1999
-$1.41 M(-47.1%)
-
-
Jun 1999
-
-$279.40 K
-$279.40 K
Dec 1998
-$2.66 M
-
-

FAQ

  • What is ANI Pharmaceuticals annual net profit?
  • What is the all time high annual net income for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual net income year-on-year change?
  • What is ANI Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly net income year-on-year change?
  • What is ANI Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM net income year-on-year change?

What is ANI Pharmaceuticals annual net profit?

The current annual net income of ANIP is $18.78 M

What is the all time high annual net income for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual net profit is $28.75 M

What is ANI Pharmaceuticals annual net income year-on-year change?

Over the past year, ANIP annual net profit has changed by +$66.67 M (+139.21%)

What is ANI Pharmaceuticals quarterly net profit?

The current quarterly net income of ANIP is -$24.17 M

What is the all time high quarterly net income for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly net profit is $21.00 M

What is ANI Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ANIP quarterly net profit has changed by -$34.11 M (-343.12%)

What is ANI Pharmaceuticals TTM net profit?

The current TTM net income of ANIP is -$7.09 M

What is the all time high TTM net income for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM net profit is $35.69 M

What is ANI Pharmaceuticals TTM net income year-on-year change?

Over the past year, ANIP TTM net profit has changed by -$20.47 M (-152.99%)